首页|芪贝胶囊联合利奈唑胺对气阴两虚型耐多药肺结核患者中医证候、病灶吸收情况的影响

芪贝胶囊联合利奈唑胺对气阴两虚型耐多药肺结核患者中医证候、病灶吸收情况的影响

扫码查看
目的:探讨芪贝胶囊联合利奈唑胺对气阴两虚型耐多药肺结核患者中医证候、病灶吸收情况的影响。方法:将2020年2月至2022年2月该院收治的120例气阴两虚型耐多药肺结核患者按照随机数字表法分为利奈唑胺组、芪贝胶囊组。利奈唑胺组60例患者给予标准抗结核方案+利奈唑胺治疗,芪贝胶囊组60例患者在利奈唑胺组的基础上加用芪贝胶囊治疗。比较两组患者的中医证候积分及病灶吸收情况。结果:治疗后,芪贝胶囊组患者咳嗽、盗汗和潮热等中医证候积分低于利奈唑胺组,病灶吸收率、痰菌转阴率高于利奈唑胺组,差异均有统计学意义(P<0。05)。治疗后,两组患者的CD4+、CD4+/CD8+水平较治疗前升高,且芪贝胶囊组患者高于利奈唑胺组;两组患者的CD8+水平较治疗前降低,且芪贝胶囊组患者低于利奈唑胺组,差异均有统计学意义(P<0。05)。结论:芪贝胶囊联合利奈唑胺治疗气阴两虚型耐多药肺结核患者,可有效降低中医证候积分,促进病灶吸收及痰菌转阴,提高免疫功能。
Effects of Qibei Capsule Combined with Linezolid on Traditional Chinese Medicine Syndrome and Lesion Absorption in Patients with Multidrug-Resistant Pulmonary Tuberculosis of Qi and Yin Deficiency Type
OBJECTIVE:To probe into the effects of Qibei capsule combined with linezolid on traditional Chinese medicine syndrome and lesion absorption in patients with multidrug-resistant pulmonary tuberculosis of Qi and Yin deficiency type.METHODS:Totally 120 patients with multidrug-resistant pulmonary tuberculosis of Qi and Yin deficiency type admitted into the hospital from Feb.2020 to Feb.2022 were extracted to be divided into the linezolid group and Qibei capsule group via the random number table method,with 60 cases in each group.The linezolid group was given standard anti-tuberculosis regimen+linezolid treatment,while the Qibei capsule group received Qibei capsule on the basis of the linezolid group.The traditional Chinese medicine syndrome scores and lesion absorption of both groups were compared.RESULTS:After treatment,the traditional Chinese medicine syndrome scores such as cough,night sweats,and hot flashes in the Qibei capsule group were lower than those in the linezolid group,and the lesion absorption rate and sputum bacterial negative conversion rate were higher than those in the linezolid group,with statistically significant differences(P<0.05).Compared with before treatment,the levels of CD4+and CD4+/CD8+in both groups increased,and the Qibei capsule group was higher than the linezolid group;the level of CD8+in both groups decreased,and the Qibei capsule group was lower than the linezolid group,with statistically significant differences(P<0.05).CONCLUSIONS:Qibei capsule combined with linezolid in the treatment of patients with multidrug-resistant pulmonary tuberculosis of Qi and Yin deficiency type can effectively decrease the traditional Chinese medicine syndrome scores in patients,promote the lesions absorption and sputum bacterial negative conversion rate,and improve immune function.

Qibei capsuleLinezolidMultidrug-resistant pulmonary tuberculosisQi and Yin deficiency typeTraditional Chinese medicine syndromeLesion absorption

李继翰、国美峰、倪磊磊、李沧友、荣立萍

展开 >

沧州市第三医院结核二科,河北沧州 061000

沧州市第三医院结核三科,河北沧州 061000

沧州市第三医院中医科,河北沧州 061000

芪贝胶囊 利奈唑胺 耐多药肺结核 气阴两虚型 中医证候 病灶吸收

河北省中医药管理局科研计划项目

2023272

2024

中国医院用药评价与分析
中国医药生物技术协会,中国药房杂志社

中国医院用药评价与分析

CSTPCD
影响因子:1.142
ISSN:1672-2124
年,卷(期):2024.24(8)